As per the report published by Kings Research, the global Digital Diabetes Management Market was valued at USD 10.78 billion in 2023. The market is projected to reach USD 27.65 billion by 2031, growing at a CAGR of 12.53% from 2024 to 2031.
The growing emphasis on patient-centric healthcare models globally is driven by the recognition of the importance of personalized care and patient involvement in healthcare decisions, thereby contributing to the growth of the digital diabetes management market. Patient-centric models prioritize individual preferences, needs, and values, shifting the focus from a disease-centered approach to a holistic approach that considers the patient's physical, emotional, and social well-being.
In diabetes management, patient-centric models empower individuals to actively participate in managing their condition through education, self-monitoring tools, and shared decision-making with healthcare providers. These models foster collaboration, trust, and accountability between patients and healthcare teams, leading to improved treatment adherence, better outcomes, and an enhanced overall quality of life for patients with diabetes.
Key Insights
- Based on product, the continuous glucose monitoring segment accounted for the largest market share of 37.34% in 2023
- Based on end user, the self/home healthcare segment is estimated to register a CAGR of 12.86% between 2024 and 2031
- On the basis of region, Asia-Pacific is anticipated to reach a valuation of USD 7.02 billion by 2031
Better Therapeutics and Glooko Partners to Integrate Digital Behavioral Diabetes Treatment
January 2024: Better Therapeutics Inc. and Glooko Inc. collaborated to merge Better Therapeutics’ AspyreRx digital behavioral treatment for type 2 diabetes (T2D) with Glooko’s diabetes management platform. AspyreRx, the first prescription-only digital therapeutic for T2D, showcased substantial reductions in A1c and cardiometabolic improvements over 180 days. This integration empowered healthcare providers in the U.S. using Glooko to identify eligible patients, prescribe AspyreRx, and monitor progress through a proven 90-day behavioral treatment accessible on smartphones.
Supportive Regulatory Environment for Digital Health Technologies to Foster Digital Diabetes Management Market Expansion
The regulatory environment for digital health technologies plays a pivotal role in the growth of the digital diabetes management market. Regulatory bodies worldwide are recognizing the potential of digital health solutions for diabetes management to improve its accessibility, efficiency, and outcomes. Focus on ensuring data privacy, security, interoperability, and adherence to quality standards for digital health products and services. These regulations provide a framework for the safe and effective use of digital health technologies, thereby fostering trust among patients, healthcare providers, and technology developers.
Compliance with these regulatory requirements enhances product credibility, accelerates market entry, and promotes widespread adoption of digital diabetes management solutions. Leading businesses are focusing on collaborative efforts between regulatory bodies, industry stakeholders, and healthcare professionals to maintain a supportive regulatory environment that balances innovation with patient safety and data protection.
Expansion in Emerging Economies with Improving Healthcare Infrastructure to Present Lucrative Opportunities
Expansion in emerging economies with improving healthcare infrastructure presents significant growth potential for the digital diabetes management market. Countries in emerging economies are witnessing rapid urbanization, rising disposable incomes, and increasing awareness regarding diabetes management. As healthcare systems evolve and infrastructure improves, the demand for advanced healthcare technologies and digital solutions is increasing. Partnerships between technology providers, healthcare organizations, and government agencies are anticipated to facilitate the adoption and integration of digital diabetes management platforms, telemedicine services, and remote monitoring solutions, particularly in in emerging economies.
Key companies are placing emphasis on tailoring solutions to address specific local healthcare needs, cultural preferences, and language diversity, thus facilitating successful market penetration and acceptance. Moreover, utilizing mobile technology, telecommunication networks, and data analytics is expected to overcome barriers to healthcare access in remote and underserved areas, thereby improving diabetes care delivery and enhancing population health outcomes.
Asia-Pacific to Record a Staggering CAGR of 14.03% Over the Forecast Period
Based on region, the global digital diabetes management market is classified into North America, Europe, Asia-Pacific, MEA, and Latin America. The Asia-Pacific region is projected to experience significant growth over the projected years. The burgeoning population in the region, combined with lifestyle changes, is contributing to a higher prevalence of diabetes and associated health complications. This demographic shift is fueling the demand for advanced diabetes management solutions, including digital health technologies.
Moreover, rapid advancements in telecommunications networks and digitalization efforts across Asia-Pacific nations are creating a conducive environment for integrating digital diabetes management platforms. Collaborations between local and international technology providers, healthcare institutions, and research organizations are driving innovation and product development tailored to healthcare systems and cultural preferences within the region.
Market Leaders Concentrate on Collaborations and Acquisitions for Sustained Growth
The global digital diabetes management market reveals a fragmented landscape featuring prominent companies including Medtronic plc, Dexcom, Inc., Abbott Laboratories, Roche Diabetes Care, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Ascensia Diabetes Care Holdings AG, Livongo Health, Inc. (now part of Teladoc Health), Senseonics Holdings, Inc., WellDoc, Inc., and others. Companies are employing a variety of strategic measures such as acquisitions, mergers, partnerships, product introductions, and collaborations to expand their global business footprint and enhance their competitive position.